Klem, L., Dumas, D., Swift, I. J., Frandsen, S. L., Mikkelsen, D. N., Fensbaek, L., Yavuz, Y., Merton, O., Castricum, J., Prichardt, S., Wynne, G. M., Riisager, A., Schultz, N., Little, P. B., Pedersen, O., Thijssen, E.
, Nykjaer, A., Kremer, P.
& Kjolby, M. (2026).
Preclinical and clinical investigation of VES001, an oral small molecule sortilin receptor inhibitor for the treatment of frontotemporal dementia: a first-in-human randomized placebo-controlled phase 1 trial.
Nature Communications ,
17(1), Article 10804.
https://doi.org/10.1038/s41467-026-77638-2
Lep, M., Plesingrova, K., Sedmik, J., Cesnarikova, S., Feole, M., Bernatik, O., Pozo Devoto, V. M., Hribkova, H., Amruz Cerna, K., Fojtik, P., Vaskovicova, N., Bartova, S., Pospisilova, V., Vanova, T.
, Andersen, O. M., Bohaciakova, D. & Raska, J. (2026).
SORL1 variant links endosomal amyloid precursor protein mis-sorting to axonal transport defects and neuronal dysfunction.
Alzheimer's and Dementia,
22(8), Article e71782.
https://doi.org/10.1002/alz.71782